Tom Flaig, MD

Thomas Flaig, MD, is a medical oncologist and has been part of the University of Colorado since 2003, when he started as an oncology fellow.  He has held a variety of administrative roles on campus, including in the School of Medicine, cancer center and UCHealth.  Most recently he was appointed vice chancellor of research for the CU Denver | CU Anschutz Medical Campus in March of 2020.   

In addition to his clinical care and administrative work, Dr. Flaig has significant clinical and translational research experience, having led both local and national multi-center clinical trials and served as the local principal investigator on a large number of clinical trials including Phase I, II and III studies.  He also runs a translational lab focused on therapeutic and biomarker development in bladder and prostate cancer.

Dr. Flaig is a member of the National Cancer Institute’s bladder cancer task force. He also serves as chair of the National Comprehensive Care Network (NCCN) bladder cancer committee and as the Co-Chair of the National Clinical Trial Network (NCTN) SWOG Bladder Committee.